Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
87,607,298
-
Shares change
-
+4,327,247
-
Total reported value, excl. options
-
$3,462,890,615
-
Value change
-
+$138,072,840
-
Put/Call ratio
-
73.5%
-
Number of buys
-
118
-
Number of sells
-
-107
-
Price
-
$39.55
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2016
263 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q1 2016.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,607,298 shares
of 99,605,545 outstanding shares and own 87.95% of the company stock.
Largest 10 shareholders include FMR LLC (12,967,607 shares), PRICE T ROWE ASSOCIATES INC /MD/ (9,575,744 shares), VANGUARD GROUP INC (6,086,722 shares), BlackRock Fund Advisors (3,223,549 shares), BB BIOTECH AG (3,121,552 shares), PERCEPTIVE ADVISORS LLC (2,720,967 shares), STATE STREET CORP (2,682,064 shares), ORBIMED ADVISORS LLC (2,653,874 shares), Invesco Ltd. (2,382,901 shares), and JANUS CAPITAL MANAGEMENT LLC (2,231,585 shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.